Global Single Use Bioreactors Market (2020 to 2025) - Patents Expiring Presents Opportunities
DUBLIN, Oct. 13, 2020 /PRNewswire/ -- The "Single Use Bioreactors Market by Product (System, Media Bag, Filtration Assemblies), Type (Stirred Tank, Bubble Column), Type of Molecule (MAbs, Vaccine), Cell Type (Mammalian, Bacteria), Application (R&D), End User (CROs & CMOs) - Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global single-use bioreactors (SUBs) market is projected to reach USD 3.90 billion by 2025 from USD 1.71 billion in 2020, at a CAGR of 18.0% during the forecast period.
Increasing adoption of SUBs among small companies and startups, reduced automation complexity, ease in the cultivation of marine organisms, reduced energy and water consumption, the growing biologics market, technological advancements in SUBs, and increasing Biopharmaceutical R&D are factors driving the growth of this market.
By type, the stirred-tank SUBs segment accounted for the largest share of the single-use bioreactors market
The single-use bioreactors market is categorized into major four types, wave-induced SUBs, stirred-tank SUBs, bubble-column SUBs, and other bioreactors. The stirred-tank SUBs segment dominated the single-use bioreactors market in 2019. The large share of this segment can be attributed to factors such as the high preference for stirred-tank SUBs in the cultivation of aerobic microbial cultures due to its ability to provide greater oxygen transfer and reduced engineering challenges such as heat removal, mass transfer, and higher agitation rates.
Asia Pacific: The fastest-growing region in the single-use bioreactors market.
The Asia Pacific market is projected to grow at the highest CAGR during the forecast period, mainly due to the growing biopharmaceutical industry, increasing life science research, rising investments by pharmaceutical and biotechnology companies, and the growing number of CROs and CMOs in several APAC countries contribute to its growth.
North America: the largest share of the single-use bioreactors market
North America accounted for the largest share of the single-use bioreactors market. Factors such as the presence of established biopharmaceutical industry and the presence of major players operating in the single-use bioreactors market in the region are the major factors driving the market growth.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
4.1 Single-Use Bioreactors Market Overview
4.2 North America: Single-Use Bioreactors Market Share, by Product & Country (2019)
4.3 Single-Use Bioreactors Market Share, by End-user, 2019
4.4 Single-Use Bioreactors Market, by Application, 2020 Vs. 2025 (USD Million)
4.5 Single-Use Bioreactors Market: Geographic Growth Opportunities
5 Industry Insights
5.1 Introduction
5.2 Key Industry Trends
5.2.1 Increasing Focus of Single-Use Bioprocessing Capacities and Technological Competitiveness
5.2.2 Increasing Adoption of Single-Use Systems by Contract Manufacturing Organizations
5.2.3 Advent of Automation in Single-Use Bioreactors
5.3 Porter's Five Forces Analysis
5.3.1 Threat from New Entrants
5.3.2 Threat from Substitutes
5.3.3 Bargaining Power of Suppliers
5.3.4 Bargaining Power of Buyers
5.3.5 Intensity of Competitive Rivalry
5.4 Value Chain Analysis
5.5 Pricing Analysis
5.6 Technological Analysis
5.6.1 Wave-Induced Motion Technology
5.6.2 Bubble-Column Technology
5.6.3 Stirred-Tank Technology
5.6.4 Vertically Perforated Discs
5.7 Impact of the COVID-19 Outbreak on the Single-Use Bioreactors Market
6 Market Overview
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.1.1 Increasing Adoption of Subs Among Small Companies and Startups
6.2.1.2 Reduced Automation Complexity
6.2.1.3 Ease in the Cultivation of Marine Organisms
6.2.1.4 Reduced Energy and Water Consumption
6.2.1.5 Growing Biologics Market
6.2.1.6 Technological Advancements in Subs
6.2.1.7 Increasing Biopharmaceutical R&D
6.2.2 Restraints
6.2.2.1 Regulatory Concerns Related to Subs
6.2.2.2 Issues Related to Leachables and Extractables
6.2.3 Opportunities
6.2.3.1 Patent Expiry
6.2.3.2 Emerging Markets
6.2.4 Challenges
6.2.4.1 Need for Improved Single-Use Sensors
6.2.4.2 Standardization of Single-Use Designs
7 Single-Use Bioreactors Market, by Product
7.1 Introduction
7.2 Single-Use Bioreactor Systems
7.2.1 The Single-Use Bioreactor Systems Segment Dominated the Market in 2019
7.2.2 Up to 10L
7.2.3 11-100L
7.2.4 101-500L
7.2.5 501-1500L
7.2.6 Above 1500L
7.3 Single-Use Media Bags
7.3.1 Expanded Applications of Single-Use Bags Across Bioprocess Operations Drive Market Growth for this Segment
7.3.2 2D Bags
7.3.3 3D Bags
7.3.4 Other Bags
7.4 Single- Use Filtration Assemblies
7.4.1 Reduced Risk of Contamination Has Propelled the Demand for Single-Use Filtration Assemblies
7.5 Other Products
8 Single-Use Bioreactors Market, by Type
8.1 Introduction
8.2 Stirred-Tank Single-Use Bioreactors
8.2.1 Stirred-Tank Subs are Mostly Preferred in the Cultivation of Aerobic Microbial Cultures
8.3 Wave-Induced Single-Use Bioreactor
8.3.1 Low-Investment Costs and Successful Applications Have Increased the Adoption of Wave-Induced Subs in the Bioreactors Market
8.4 Bubble-Column Single-Use Bioreactor
8.4.1 Greater Mass and Heat Transfer Efficiencies Drive the Growth of this Segment
8.5 Other Single-Use Bioreactors
9 Single-Use Bioreactors Market, by Type of Cell
9.1 Introduction
9.2 Mammalian Cells
9.2.1 Mammalian Cells are Most Widely Used in Biomanufacturing Owing to Its Highly Mechanized Metabolic Machinery
9.3 Bacterial Cells
9.3.1 Use of Bacterial Cells in Commercial Vaccines and Recombinant Protein Production Drives the Market Growth
9.4 Yeast Cells
9.4.1 Faster Growth Rate and Minimal Requirement of Growth Media Conditions Drive the Adoption of Yeast Cells in Recombinant Protein Production
9.5 Other Cells
10 Single-Use Bioreactors Market, by Type of Molecule
10.1 Introduction
10.2 Monoclonal Antibodies
10.2.1 Growing Therapeutic Applications of Mabs to Drive the Demand for Subs in R&D and Manufacturing Applications
10.3 Vaccines
10.3.1 Implementation of Subs for Vaccine Production Maximizes Facility Output and Increases Revenue
10.4 Stem Cells
10.4.1 Wide Applications of Stem Cell Therapies for Disease Treatment Drives the Market Growth of this Segment
10.5 Gene-Modified Cells
10.5.1 The Growing Market of Gene and Cell Therapies for Neurological Diseases and Cancer to Drive the Growth of this Segment
10.6 Oher Molecules
11 Single-Use Bioreactors Market, by Application
11.1 Introduction
11.2 Bioproduction
11.2.1 Increasing Competition for New Indications and the Launch of Biosimilars Drives the Demand for Cost-Effective Subs
11.3 Process Development
11.3.1 Reduced Risk of Cross-Contamination and Reduced Operational Costs Make Subs the Most Preferred Solution for Process Development
11.4 Research and Development
11.4.1 Subs are Increasingly Adopted for R&D Applications as It is an Economical and Flexible Option
12 Single-Use Bioreactors Market, by End-user
12.1 Introduction
12.2 Pharmaceutical & Biopharmaceutical Companies
12.2.1 Increasing Pharmaceutical R&D Spending is Driving the Demand for Single-Use Bioreactors
12.3 Contract Research Organizations (Cros) and Contract Manufacturing Organizations (Cmos)
12.3.1 Increasing Outsourcing of R&D Services by Pharmaceutical & Biopharmaceutical Companies to Support Market Growth
12.4 Academic & Research Institutes
12.4.1 Growing Collaborations Between Pharmaceutical & Biopharmaceutical Manufacturers and Research Institutes to Drive Market Growth
13 Single-Use Bioreactors Market, by Region
13.1 Introduction
13.2 North America
13.2.1 US
13.2.1.1 The Us Dominates the North American Single-Use Bioreactors Market During the Forecast Period
13.2.2 Canada
13.2.2.1 Growing Number of Biopharmaceutical Manufacturing Facilities is Supporting the Growth of the Market in Canada
13.3 Europe
13.3.1 Germany
13.3.1.1 Increasing Adoption of Single-Use Bioreactors by Biopharma and Cdmo Companies Will Drive Market Growth
13.3.2 UK
13.3.2.1 Rising Government Support for Biotech Companies to Propel the Demand for Advanced Technologies, Including Single-Use Bioreactors in the UK
13.3.3 France
13.3.3.1 Increasing Investments in Life Science R&D Infrastructure Development to Support Market Growth
13.3.4 Rest of Europe (Roe)
13.4 Asia-Pacific
13.4.1 Significant Investments by Biopharmaceutical Companies & Cmos in Emerging APAC Countries to Drive Market Growth
13.4.2 China
13.4.2.1 Local Government Support Contributes to the Growth of the Biopharma Industry, Thus Supplementing Market Growth in China
13.4.3 Japan
13.4.3.1 Expansion of Pharmaceutical Manufacturing Plants in Japan Has Created Growth Opportunities for Sub Companies
13.4.4 India
13.4.4.1 Growth of the Indian Pharmaceutical Industry Creates Significant Demand for Subs
13.4.5 South Korea
13.4.5.1 Increasing Annual Drug Exports and Quality Manufacturing Practices Drive Market Growth in South Korea
13.4.6 RoAPAC
13.5 Latin America (Latam)
13.5.1 Growth in the Generic Drug Market Will Increase the Demand for Single-Use Bioreactors in this Region
13.6 Middle East and Africa (Mea)
14 Competitive Landscape
14.1 Market Evaluation Framework
14.2 Right-To-Win Approaches Adopted by Key Market Players
14.3 Revenue Analysis of Top Market Players
14.4 Global Single-User Bioreactors Market: Company Evaluation Quadrant, 2019
14.4.1 Stars
14.4.2 Emerging Leaders
14.4.3 Pervasive
14.4.4 Emerging Companies
14.5 Global Single-Use Bioreactors Market: Start-Ups/ SMEs Evaluation Matrix, 2019
14.5.1 Progressive Companies
14.5.2 Starting Blocks
14.5.3 Responsive Companies
14.5.4 Dynamic Companies
14.6 Key Market Developments
14.6.1 Key Product Launches
14.6.2 Key Acquisitions
14.6.3 Key Partnerships, Agreements, Alliances, and Collaborations
14.6.4 Key Expansions
15 Company Profiles
15.1 Sartorius Stedim Biotech
15.2 Danaher Corporation
15.3 Thermo Fisher Scientific Inc.
15.4 Merck Millipore
15.5 Getinge Ab
15.6 Eppendorf Ag
15.7 Cesco Bioengineering Co., Ltd.
15.8 Cellexus
15.9 PBS Biotech, Inc.
15.10 Distek, Inc.
15.11 ABEC, Inc.
15.12 Able Corporation & Biott Corporation
15.13 G&G Technologies, Inc.
15.14 Solida Biotech GmbH
15.15 Satake Chemical Equipment Mfg., Ltd.
15.16 Stobbe Pharma GmbH
15.17 Celltainer Biotech Bv
15.18 Meissner Filtration Products, Inc.
15.19 Bbi-Biotech GmbH
15.20 Pierre Gurin
16 Appendix
16.1 Discussion Guide
16.2 Knowledge Store: The Subscription Portal
16.3 Available Customizations
For more information about this report visit https://www.researchandmarkets.com/r/wezx6i
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article